Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cambridge Nutraceuticals is a science-led health supplement company based in Cambridge, UK, operating primarily through its flagship brand, FutureYou Cambridge. Founded in 2012 with close ties to the University of Cambridge, the company focuses on developing highly bioavailable nutritional supplements supported by published clinical data. Its product portfolio includes patented formulations such as LactoLycopene (Ateronon Heart+) and Meriva curcumin (Turmeric+), which have been tested in clinical trials at institutions like Cambridge University Hospitals. The company has expanded its reach through the acquisition of specialized brands like Prime Fifty and GP Nutrition, targeting demographics ranging from the over-50s to the beauty and longevity sectors. Cambridge Nutraceuticals is committed to scientific transparency, ensuring that every product in its range is backed by rigorous research and academic expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CamNutra.